[Federal Register Volume 68, Number 209 (Wednesday, October 29, 2003)]
[Notices]
[Pages 61698-61699]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-27238]


-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.33(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on June 20, 2003, and September 
2, 2003, Cody Laboratories, Inc., 331 33rd Street, Cody, Wyoming 82414, 
made application by renewal to the Drug Enforcement Administration 
(DEA) for registration as a bulk manufacturer of the basic classes of 
controlled substances listed below:

------------------------------------------------------------------------
                   Drug                               Schedule
------------------------------------------------------------------------
Amphetamine (1100).......................  Schedule II
Methamphetamine (1105)...................  Schedule II
Amobarbital (2125).......................  Schedule II
Pentobarbital (2270).....................  Schedule II
Secobarbital (2315)......................  Schedule II
Oxycodone (9143).........................  Schedule II
Hydromorphone (9150).....................  Schedule II
Diphenoxylate (9170).....................  Schedule II
Meperidine (9230)........................  Schedule II
Oxymorphone (9652).......................  Schedule II
Sufentanil (9740)........................  Schedule II
Fentanyl (9801)..........................  Schedule II
------------------------------------------------------------------------

    The firm plans to manufacture bulk materials for distribution to 
its customers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the proposed registration. Any such comments or 
objections may be addressed, in quintuplicate, to the

[[Page 61699]]

Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCD) and must be filed no later than December 29, 2003.

    Dated: October 7, 2003.
Laura M. Nagel,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 03-27238 Filed 10-28-03; 8:45 am]
BILLING CODE 4410-09-M